Enfortumab vedotin plus pembrolizumab in the treatment of locally advanced or metastatic bladder cancer of variant histology: A phase II study

被引：0
|
作者：
Nazha, Bassel
Brown, Jacqueline T.
Liu, Yuan
Kissick, Haydn
Carthon, Bradley Curtis
Kucuk, Omer
Harik, Lara R.
Narayan, Vikram M.
Joshi, Shreyas S.
Bilen, Mehmet Asim
机构：
[1] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA USA
[2] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA USA
[3] Emory Univ, Dept Urol, Sch Med, Atlanta, GA USA
[4] Emory Univ, Dept Pathol, Sch Med, Atlanta, GA USA
[5] Emory Univ, Dept Urol, Atlanta, GA USA
[6] Emory Univ, Winship Canc Inst, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4615
引用
收藏
页数：1
相关论文
共 50 条
  • [1] FDA OKs Enfortumab Vedotin Plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer
    不详
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (02):
  • [2] EV-103: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for locally advanced or metastatic urothelial cancer.
    Hoimes, Christopher J.
    Rosenberg, Jonathan E.
    Petrylak, Daniel Peter
    Carret, Anne-Sophie
    Melhem-Bertrandt, Amal
    Flaig, Thomas W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab
    Hoimes, Christopher J.
    Flaig, Thomas W.
    Milowsky, Matthew, I
    Friedlander, Terence W.
    Bilen, Mehmet Asim
    Gupta, Shilpa
    Srinivas, Sandy
    Merchan, Jaime R.
    Mckay, Rana R.
    Petrylak, Daniel P.
    Sasse, Carolyn
    Moreno, Blanca Homet
    Yu, Yao
    Carret, Anne-Sophie
    Rosenberg, Jonathan E.
    FUTURE ONCOLOGY, 2024, 20 (07) : 351 - 360
  • [4] Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context
    Hoffman-Censits, Jean
    Maldonado, Laneisha
    ONCOTARGETS AND THERAPY, 2022, 15 : 1519 - 1529
  • [5] Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer
    Taylor, Caroline
    Patterson, Kamai M.
    Friedman, Devira
    Bacot, Silvia M.
    Feldman, Gerald M.
    Wang, Tao
    CANCERS, 2024, 16 (17)
  • [6] EV-103: Initial results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma
    Hoimes, C. J.
    Rosenberg, J. E.
    Srinivas, S.
    Petrylak, D. P.
    Milowsky, M.
    Merchan, J. R.
    Bilen, M. A.
    Gupta, S.
    Carret, A-S.
    Yuan, N.
    Melhem-Bertrandt, A.
    Flaig, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 356 - 356
  • [7] The EV-103 Trial: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for patients with locally advanced or metastatic urothelial
    Hoimes, Christopher J.
    Rosenberg, Jonathan E.
    Petrylak, Daniel P.
    Carret, Anne-Sophie
    Melhem-Bertrandt, Amal
    Flaig, Thomas W.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 43 - 43
  • [8] Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer
    Hoimes, Christopher J.
    Flaig, Thomas W.
    Milowsky, Matthew, I
    Friedlander, Terence W.
    Bilen, Mehmet Asim
    Gupta, Shilpa
    Srinivas, Sandy
    Merchan, Jaime R.
    McKay, Rana R.
    Petrylak, Daniel P.
    Sasse, Carolyn
    Moreno, Blanca Homet
    Yu, Yao
    Carret, Anne-Sophie
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (01) : 22 - +
  • [9] Study EV-103: Durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma.
    Rosenberg, Jonathan E.
    Flaig, Thomas W.
    Friedlander, Terence W.
    Milowsky, Matthew, I
    Srinivas, Sandy
    Petrylak, Daniel Peter
    Merchan, Jaime R.
    Bilen, Mehmet Asim
    Carret, Anne-Sophie
    Yuan, Nancy
    Sasse, Carolyn
    Hoimes, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Study EV-103: Preliminary durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma
    Rosenberg, Jonathan E.
    Flaig, Thomas W.
    Friedlander, Terence W.
    Milowsky, Matthew I.
    Srinivas, Sandy
    Petrylak, Daniel Peter
    Merchan, Jaime R.
    Bilen, Mehmet Asim
    Carret, Anne-Sophie
    Yuan, Nancy
    Sasse, Carolyn
    Hoimes, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345